Inhibition of collagenase by aranciamycin and aranciamycin derivatives
Aranciamycin (1), an anthracycline antibiotic, was found to be an inhibitor of Clostridium histolyticum collagenase, with an IC50 = 3.7 x 10(-7) M. Elastase and trypsin were not inhibited at concentrations less-than-or-equal-to 10(-5) M. A number of aranciamycin derivatives 2-13 were prepared and te...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 1992-07, Vol.35 (15), p.2768-2771 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2771 |
---|---|
container_issue | 15 |
container_start_page | 2768 |
container_title | Journal of medicinal chemistry |
container_volume | 35 |
creator | Bols, Mikael Binderup, Lise Hansen, Jytte Rasmussen, Poul |
description | Aranciamycin (1), an anthracycline antibiotic, was found to be an inhibitor of Clostridium histolyticum collagenase, with an IC50 = 3.7 x 10(-7) M. Elastase and trypsin were not inhibited at concentrations less-than-or-equal-to 10(-5) M. A number of aranciamycin derivatives 2-13 were prepared and tested for collagenase inhibition. While loss of activity was found for derivatives modified in the sugar ring or rings B and D of the aglycone, increased potency was found when the tertiary alcohol at C-9 was esterified. All compounds 1-13 were found to inhibit DNA synthesis of Yoshida sarcoma tumor cells. |
doi_str_mv | 10.1021/jm00093a008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_A1992JF49600008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73097022</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-d48f9951fba7d4c02ae1e6631bbdf31ed3de098fadfcec2ab398686d9c8ffdab3</originalsourceid><addsrcrecordid>eNqNkc1v1DAQxS0EKtvCiTNSDogeUIo_skl8rFZd6IcEokVIXKyJPQYvG7vYScv-97jNagsSB06WPb83b_yGkBeMHjHK2dtVTymVAihtH5EZm3NaVi2tHpMZpZyXvObiKdlPaZUxwbjYI3tMcC7bekaWp_6769zggi-CLXRYr-EbekhYdJsCInjtoN9o5wvw5u8Hg9HdwOBuMD0jTyysEz7fngfk8_LkavG-vPjw7nRxfFGCaMVQmqq1Us6Z7aAxlaYckGFdC9Z1xgqGRhiksrVgrEbNoRN5yLY2UrfWmnw9IK-nvtcx_BwxDap3SWMe2mMYk2oElU3-dAbfTKCOIaWIVl1H10PcKEbVXWrqj9Qy_XLbdux6NA_sFFOuv9rWIWlY2_sU0g6bV6KmonowvcUu2KQdeo076phJyc-Wlayz8b1p-__0wg1wt6RFGP2QpeUkdWnAXzsNxB-qbkQzV1cfLxWtzr-yL58u1VnmDycedFKrMEafl_TPJH4D_LWypQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73097022</pqid></control><display><type>article</type><title>Inhibition of collagenase by aranciamycin and aranciamycin derivatives</title><source>Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Bols, Mikael ; Binderup, Lise ; Hansen, Jytte ; Rasmussen, Poul</creator><creatorcontrib>Bols, Mikael ; Binderup, Lise ; Hansen, Jytte ; Rasmussen, Poul</creatorcontrib><description>Aranciamycin (1), an anthracycline antibiotic, was found to be an inhibitor of Clostridium histolyticum collagenase, with an IC50 = 3.7 x 10(-7) M. Elastase and trypsin were not inhibited at concentrations less-than-or-equal-to 10(-5) M. A number of aranciamycin derivatives 2-13 were prepared and tested for collagenase inhibition. While loss of activity was found for derivatives modified in the sugar ring or rings B and D of the aglycone, increased potency was found when the tertiary alcohol at C-9 was esterified. All compounds 1-13 were found to inhibit DNA synthesis of Yoshida sarcoma tumor cells.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00093a008</identifier><identifier>PMID: 1322986</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>WASHINGTON: American Chemical Society</publisher><subject>Alicyclic compounds ; Alicyclic compounds, terpenoids, prostaglandins, steroids ; Animals ; Anthracyclines ; Antibiotics, Antineoplastic - chemistry ; Antibiotics, Antineoplastic - pharmacology ; Chemistry ; Chemistry, Medicinal ; Exact sciences and technology ; Life Sciences & Biomedicine ; Magnetic Resonance Spectroscopy ; Microbial Collagenase - antagonists & inhibitors ; Organic chemistry ; Pancreatic Elastase - antagonists & inhibitors ; Pharmacology & Pharmacy ; Preparations and properties ; Rats ; Sarcoma, Experimental ; Science & Technology ; Streptomyces - chemistry ; Trypsin Inhibitors - pharmacology ; Tumor Cells, Cultured</subject><ispartof>Journal of medicinal chemistry, 1992-07, Vol.35 (15), p.2768-2771</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>30</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wosA1992JF49600008</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-a383t-d48f9951fba7d4c02ae1e6631bbdf31ed3de098fadfcec2ab398686d9c8ffdab3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00093a008$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00093a008$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,782,786,2769,27085,27201,27933,27934,56747,56797</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5436034$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1322986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bols, Mikael</creatorcontrib><creatorcontrib>Binderup, Lise</creatorcontrib><creatorcontrib>Hansen, Jytte</creatorcontrib><creatorcontrib>Rasmussen, Poul</creatorcontrib><title>Inhibition of collagenase by aranciamycin and aranciamycin derivatives</title><title>Journal of medicinal chemistry</title><addtitle>J MED CHEM</addtitle><addtitle>J. Med. Chem</addtitle><description>Aranciamycin (1), an anthracycline antibiotic, was found to be an inhibitor of Clostridium histolyticum collagenase, with an IC50 = 3.7 x 10(-7) M. Elastase and trypsin were not inhibited at concentrations less-than-or-equal-to 10(-5) M. A number of aranciamycin derivatives 2-13 were prepared and tested for collagenase inhibition. While loss of activity was found for derivatives modified in the sugar ring or rings B and D of the aglycone, increased potency was found when the tertiary alcohol at C-9 was esterified. All compounds 1-13 were found to inhibit DNA synthesis of Yoshida sarcoma tumor cells.</description><subject>Alicyclic compounds</subject><subject>Alicyclic compounds, terpenoids, prostaglandins, steroids</subject><subject>Animals</subject><subject>Anthracyclines</subject><subject>Antibiotics, Antineoplastic - chemistry</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Chemistry</subject><subject>Chemistry, Medicinal</subject><subject>Exact sciences and technology</subject><subject>Life Sciences & Biomedicine</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Microbial Collagenase - antagonists & inhibitors</subject><subject>Organic chemistry</subject><subject>Pancreatic Elastase - antagonists & inhibitors</subject><subject>Pharmacology & Pharmacy</subject><subject>Preparations and properties</subject><subject>Rats</subject><subject>Sarcoma, Experimental</subject><subject>Science & Technology</subject><subject>Streptomyces - chemistry</subject><subject>Trypsin Inhibitors - pharmacology</subject><subject>Tumor Cells, Cultured</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EZCTM</sourceid><sourceid>EIF</sourceid><recordid>eNqNkc1v1DAQxS0EKtvCiTNSDogeUIo_skl8rFZd6IcEokVIXKyJPQYvG7vYScv-97jNagsSB06WPb83b_yGkBeMHjHK2dtVTymVAihtH5EZm3NaVi2tHpMZpZyXvObiKdlPaZUxwbjYI3tMcC7bekaWp_6769zggi-CLXRYr-EbekhYdJsCInjtoN9o5wvw5u8Hg9HdwOBuMD0jTyysEz7fngfk8_LkavG-vPjw7nRxfFGCaMVQmqq1Us6Z7aAxlaYckGFdC9Z1xgqGRhiksrVgrEbNoRN5yLY2UrfWmnw9IK-nvtcx_BwxDap3SWMe2mMYk2oElU3-dAbfTKCOIaWIVl1H10PcKEbVXWrqj9Qy_XLbdux6NA_sFFOuv9rWIWlY2_sU0g6bV6KmonowvcUu2KQdeo076phJyc-Wlayz8b1p-__0wg1wt6RFGP2QpeUkdWnAXzsNxB-qbkQzV1cfLxWtzr-yL58u1VnmDycedFKrMEafl_TPJH4D_LWypQ</recordid><startdate>19920701</startdate><enddate>19920701</enddate><creator>Bols, Mikael</creator><creator>Binderup, Lise</creator><creator>Hansen, Jytte</creator><creator>Rasmussen, Poul</creator><general>American Chemical Society</general><general>Amer Chemical Soc</general><scope>BSCLL</scope><scope>BLEPL</scope><scope>DTL</scope><scope>EZCTM</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19920701</creationdate><title>Inhibition of collagenase by aranciamycin and aranciamycin derivatives</title><author>Bols, Mikael ; Binderup, Lise ; Hansen, Jytte ; Rasmussen, Poul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-d48f9951fba7d4c02ae1e6631bbdf31ed3de098fadfcec2ab398686d9c8ffdab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Alicyclic compounds</topic><topic>Alicyclic compounds, terpenoids, prostaglandins, steroids</topic><topic>Animals</topic><topic>Anthracyclines</topic><topic>Antibiotics, Antineoplastic - chemistry</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Chemistry</topic><topic>Chemistry, Medicinal</topic><topic>Exact sciences and technology</topic><topic>Life Sciences & Biomedicine</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Microbial Collagenase - antagonists & inhibitors</topic><topic>Organic chemistry</topic><topic>Pancreatic Elastase - antagonists & inhibitors</topic><topic>Pharmacology & Pharmacy</topic><topic>Preparations and properties</topic><topic>Rats</topic><topic>Sarcoma, Experimental</topic><topic>Science & Technology</topic><topic>Streptomyces - chemistry</topic><topic>Trypsin Inhibitors - pharmacology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bols, Mikael</creatorcontrib><creatorcontrib>Binderup, Lise</creatorcontrib><creatorcontrib>Hansen, Jytte</creatorcontrib><creatorcontrib>Rasmussen, Poul</creatorcontrib><collection>Istex</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 1992</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bols, Mikael</au><au>Binderup, Lise</au><au>Hansen, Jytte</au><au>Rasmussen, Poul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of collagenase by aranciamycin and aranciamycin derivatives</atitle><jtitle>Journal of medicinal chemistry</jtitle><stitle>J MED CHEM</stitle><addtitle>J. Med. Chem</addtitle><date>1992-07-01</date><risdate>1992</risdate><volume>35</volume><issue>15</issue><spage>2768</spage><epage>2771</epage><pages>2768-2771</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Aranciamycin (1), an anthracycline antibiotic, was found to be an inhibitor of Clostridium histolyticum collagenase, with an IC50 = 3.7 x 10(-7) M. Elastase and trypsin were not inhibited at concentrations less-than-or-equal-to 10(-5) M. A number of aranciamycin derivatives 2-13 were prepared and tested for collagenase inhibition. While loss of activity was found for derivatives modified in the sugar ring or rings B and D of the aglycone, increased potency was found when the tertiary alcohol at C-9 was esterified. All compounds 1-13 were found to inhibit DNA synthesis of Yoshida sarcoma tumor cells.</abstract><cop>WASHINGTON</cop><pub>American Chemical Society</pub><pmid>1322986</pmid><doi>10.1021/jm00093a008</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 1992-07, Vol.35 (15), p.2768-2771 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_webofscience_primary_A1992JF49600008 |
source | Web of Science - Science Citation Index Expanded - 1992<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; MEDLINE; American Chemical Society Journals |
subjects | Alicyclic compounds Alicyclic compounds, terpenoids, prostaglandins, steroids Animals Anthracyclines Antibiotics, Antineoplastic - chemistry Antibiotics, Antineoplastic - pharmacology Chemistry Chemistry, Medicinal Exact sciences and technology Life Sciences & Biomedicine Magnetic Resonance Spectroscopy Microbial Collagenase - antagonists & inhibitors Organic chemistry Pancreatic Elastase - antagonists & inhibitors Pharmacology & Pharmacy Preparations and properties Rats Sarcoma, Experimental Science & Technology Streptomyces - chemistry Trypsin Inhibitors - pharmacology Tumor Cells, Cultured |
title | Inhibition of collagenase by aranciamycin and aranciamycin derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T12%3A14%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20collagenase%20by%20aranciamycin%20and%20aranciamycin%20derivatives&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Bols,%20Mikael&rft.date=1992-07-01&rft.volume=35&rft.issue=15&rft.spage=2768&rft.epage=2771&rft.pages=2768-2771&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00093a008&rft_dat=%3Cproquest_webof%3E73097022%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73097022&rft_id=info:pmid/1322986&rfr_iscdi=true |